Download our article to find out how Enzyme Indicators have transformed the productivity of AstraZeneca's VPHP cycle.
Callum Dew is a Senior Scientist in Microbiology, New Modalities and Parenteral Development for Pharmaceutical Technology & Development Operations at AstraZeneca UK. In this white paper, he discusses how his organization has used Enzyme Indicators (EIs) to optimize the VPHP decontamination cycle and what results this has led to.
He details some of the challenges involved in the manufacturing process for sterile pharmaceuticals and the importance of streamlining these activities to deliver improved productivity without the need for large-scale investment.
The white paper also explains:
- How to assess a bio-decontamination cycle.
- How AstraZeneca has implemented EIs in order to optimize its VPHP cycle.
- How this has led to a greater than 75 percent improvement in isolator productivity in just ten days.
Download the full white paper below to learn more about what EI technology has achieved for AstraZeneca and how it could help your business.
Please complete the form below to receive a copy of the Article.
